Conference Speakers

Conference Speakers and Panelists | 2025

Kate Bingham

Managing Partner, SV Health Investors

Jeremy Caldwell, Ph.D.

Partner, Red Tree Venture Capital

Mira Chaurushiya, Ph.D.

Managing Director, Westlake Village BioPartners

Shelley Chu, M.D., Ph.D.

Partner, Lightspeed Ventures

Thomas Daniel, M.D.

Director, Scripps Research; Chair & Founder, Life Science Cares San Diego

Jennifer Giottonini Cayer

Chief Business Officer, Pulmocide

Richard Glynne, Ph.D.

Venture Partner; President & CSO, Inception Therapeutics Discovery Engine, Versant Ventures

Tony Ho

Chief Scientific Officer & Senior Science Partner, Pivotal Life Sciences

John Hood, Ph.D.

Founder, CEO & Executive Chairman, Endeavor BioMedicines

Rachna Khosla

Senior Vice President, Business Development, Amgen

Nina Kjellson

General Partner, Canaan Partners

John Lepore, M.D.

CEO, ProFound Therapeutics; CEO-Partner, Flagship Pioneering

Jay Lichter

Managing Director, Avalon Ventures; President and CEO, Arialys Therapeutics

Bill Martin, Ph.D.

Global Therapeutic Area Head, Neuroscience, The Janssen Pharmaceutical Companies of Johnson & Johnson

Shlomo Melmed, M.D.

Dean, Cedars-Sinai Medical Center

Detlev Mennerich, Ph.D.

Corporate SVP, Global Head of Business Development & Licensing, Boehringer Ingelheim

Thomas Miller

Co-Founder & CEO, Iambic Therapeutics

Daria Mochly-Rosen, Ph.D.

The George D. Smith Professor of Translational Medicine, Stanford University School of Medicine; Founder, Spark at Stanford

Carolyn Ng, Ph.D.

Partner & Managing Director, TPG Life Sciences Innovations

Carole Nuechterlein

Head, Roche Venture Fund

Daniel O’Connell, M.D., Ph.D.

Partner, Novo Ventures

Deborah Palestrant, Ph.D.

Partner & Executive Chair, 4:59 Initiative, 5AM Ventures

Mark Paris, Ph.D.

Executive Director, Oncology Search and Evaluation, Daiichi Sankyo

Sunil Patel

Head of Corporate Development and Business Development & Licensing, Merck

Steven Paul, M.D.

Board Chair, FNIH; Venture Partner, Third Rock Ventures

Jeremy Quirk

VP BD&L Commercial Portfolio, GSK

John Reed, M.D., Ph.D.

EVP, Pharmaceuticals, Research & Development, The Janssen Pharmaceutical Companies of Johnson & Johnson

Mary Rozenman, Ph.D.

CFO & CBO, insitro

Camille Samuels

Partner, Venrock

James Schaeffer, Ph.D.

Vice President, Business Strategy, PhenoTarget

Avi Spier, Ph.D.

Executive Director, Search & Evaluation, Novartis

Jay Stamatis

Vice President, Head of Business Development and Acquisitions, AbbVie

Matt Tremblay, Ph.D.

Chief Executive Officer, Blackbird Laboratories

Court Turner

Partner, LYZZ Capital

D.A. Wallach

General Partner & Co-Founder, Time BioVentures